VYGR: Voyager Therapeutics, Inc. Stock

by  •  • Comments Off on VYGR: Voyager Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 172.80
Enterprise Value ($M) 101.43
Book Value ($M) 299.76
Book Value / Share 5.43
Price / Book 0.58
NCAV ($M) 183.52
NCAV / Share 3.32
Price / NCAV 0.94

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 5.56
Current Ratio 5.56

Balance Sheet (mrq) ($M)
Current Assets 276.81
Assets 393.05
Liabilities 93.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 80.00
Operating Income -83.29
Net Income -65.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.31
Cash from Investing -94.86
Cash from Financing 114.02

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.88 3.77
11-14 13G/A EcoR1 Capital, LLC 9.99 45.86
08-07 13G/A BlackRock, Inc. 10.00 107.39

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 51,552 311,128 16.57
2025-04-16 47,357 203,741 23.24
2025-04-15 40,029 237,844 16.83
2025-04-14 44,246 218,405 20.26

(click for more detail)

Similar Companies
VRTX – Vertex Pharmaceuticals Incorporated VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc. XBIT – XBiotech Inc.
XERS – Xeris Biopharma Holdings, Inc.


Financial data and stock pages provided by
Fintel.io